These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16274294)
41. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Pan YX; Xu J; Bolan E; Abbadie C; Chang A; Zuckerman A; Rossi G; Pasternak GW Mol Pharmacol; 1999 Aug; 56(2):396-403. PubMed ID: 10419560 [TBL] [Abstract][Full Text] [Related]
42. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Schuller AG; King MA; Zhang J; Bolan E; Pan YX; Morgan DJ; Chang A; Czick ME; Unterwald EM; Pasternak GW; Pintar JE Nat Neurosci; 1999 Feb; 2(2):151-6. PubMed ID: 10195199 [TBL] [Abstract][Full Text] [Related]
43. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia. Lu Z; Xu J; Xu M; Rossi GC; Majumdar S; Pasternak GW; Pan YX Anesth Analg; 2018 Mar; 126(3):1050-1057. PubMed ID: 28991118 [TBL] [Abstract][Full Text] [Related]
44. Sex Associated Differential Expressions of the Alternatively Spliced Variants mRNA of OPRM1 in Brain Regions of C57BL/6 Mouse. Liu A; Zhang H; Qin F; Wang Q; Sun Q; Xie S; Wang Q; Tang Z; Lu Z Cell Physiol Biochem; 2018; 50(4):1441-1459. PubMed ID: 30359988 [TBL] [Abstract][Full Text] [Related]
45. Mu Opioid Pharmacology: 40 Years to the Promised Land. Pasternak GW Adv Pharmacol; 2018; 82():261-291. PubMed ID: 29413524 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system. Zhang Y; Pan YX; Kolesnikov Y; Pasternak GW Brain Res; 2006 Jul; 1099(1):33-43. PubMed ID: 16793025 [TBL] [Abstract][Full Text] [Related]
47. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. Koch T; Schulz S; Schröder H; Wolf R; Raulf E; Höllt V J Biol Chem; 1998 May; 273(22):13652-7. PubMed ID: 9593704 [TBL] [Abstract][Full Text] [Related]
48. Murine chromosomal location of the mu and kappa opioid receptor genes. Kozak CA; Filie J; Adamson MC; Chen Y; Yu L Genomics; 1994 Jun; 21(3):659-61. PubMed ID: 7959748 [TBL] [Abstract][Full Text] [Related]
49. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats. Leventhal L; Silva RM; Rossi GC; Pasternak GW; Bodnar RJ J Pharmacol Exp Ther; 1998 Nov; 287(2):538-44. PubMed ID: 9808678 [TBL] [Abstract][Full Text] [Related]
50. Mu opioid receptors in pain management. Pasternak G; Pan YX Acta Anaesthesiol Taiwan; 2011 Mar; 49(1):21-5. PubMed ID: 21453899 [TBL] [Abstract][Full Text] [Related]
51. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice. Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973 [TBL] [Abstract][Full Text] [Related]
52. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. Rossi GC; Leventhal L; Pan YX; Cole J; Su W; Bodnar RJ; Pasternak GW J Pharmacol Exp Ther; 1997 Apr; 281(1):109-14. PubMed ID: 9103486 [TBL] [Abstract][Full Text] [Related]
53. Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X Signaling. Regan PM; Sariyer IK; Langford TD; Datta PK; Khalili K J Cell Physiol; 2016 Jul; 231(7):1542-53. PubMed ID: 26553431 [TBL] [Abstract][Full Text] [Related]
54. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Chen Y; Mestek A; Liu J; Hurley JA; Yu L Mol Pharmacol; 1993 Jul; 44(1):8-12. PubMed ID: 8393525 [TBL] [Abstract][Full Text] [Related]
55. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Noble F; Cox BM Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226 [TBL] [Abstract][Full Text] [Related]
56. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Zhang J; Ferguson SS; Barak LS; Bodduluri SR; Laporte SA; Law PY; Caron MG Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7157-62. PubMed ID: 9618555 [TBL] [Abstract][Full Text] [Related]
57. Mu opiate receptor subtypes. Cadet P Med Sci Monit; 2004 Jun; 10(6):MS28-32. PubMed ID: 15173681 [TBL] [Abstract][Full Text] [Related]
58. Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. Dever SM; Xu R; Fitting S; Knapp PE; Hauser KF J Neurovirol; 2012 Jun; 18(3):181-90. PubMed ID: 22528479 [TBL] [Abstract][Full Text] [Related]
59. A major species of mouse mu-opioid receptor mRNA and its promoter-dependent functional polyadenylation signal. Wu Q; Hwang CK; Yao S; Law PY; Loh HH; Wei LN Mol Pharmacol; 2005 Aug; 68(2):279-85. PubMed ID: 15879516 [TBL] [Abstract][Full Text] [Related]
60. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Guang W; Wang H; Su T; Weinstein IB; Wang JB Mol Pharmacol; 2004 Nov; 66(5):1285-92. PubMed ID: 15496510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]